The QualityStocks Daily Wednesday, January 2nd, 2019

Today's Top 3 StockMarketWatch

StockMarketWatch (OPI) +295.63%

Kiplinger Today (SHLDQ) +82.16%

QualityStocks (STNN) +52.38%

The QualityStocks Daily Stock List

Tinka Resources Limited (TKRFF)

Hotstocked, TradingView, Northern Miner, InvestorsHub, MarketWatch, Investors Hangout, OTC Markets, Junior Mining Network, Streetwise Reports, Canadian Insider, Wallet Investor, Dividend Investor, The Prospector News, 24hgold, Barchart, Stockhouse, and InvestingNews reported earlier on Tinka Resources Limited (TKRFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Tinka Resources Limited is an exploration and development company based in Vancouver, British Columbia. Its flagship property is the 100 percent-owned Ayawilca carbonate replacement deposit (CRD) in the zinc-lead-silver belt of central Peru (200 kilometers northeast of Lima). Tinka Resources owns 100 percent of the contiguous 150 km2 mining concessions at Ayawilca. The Company is focusing on growing the Ayawilca Mineral Resources.

Three NI 43-101 Mineral Resources exist on the Property. The Zinc Zone and Tin Zone resources are thought to be mineable by underground methods for resource calculation purposes. The Colquipucro Silver Zone is thought to be mineable by open pit methods.

The Ayawilca Zinc Zone Inferred Mineral Resource estimate presently consists of 42.7 Mt at 6.0 % zinc, 0.2 % lead, 17 g/t silver, and 79 g/t indium. Additionally, it consists of a Tin Zone Inferred Mineral Resource of 10.5 Mt at 0.63 % tin, 0.23 % copper & 12 g/t silver.

Recently, Tinka Resources announced that it formally started a Preliminary Economic Assessment (PEA) on the Ayawilca Zinc and Tin Project in Peru. Wood (previously Amec Foster Wheeler) in Lima, Peru, has been engaged as lead consultant to prepare the PEA. Wood is a worldwide leader in the delivery of project, engineering and technical services to energy and industrial markets.

Furthermore, Tinka Resources announced the appointment of Mr. Ken Engquist as Managing Consultant, Project Development. Mr. Engquist will oversee development of the PEA on behalf of Tinka. His track record and wide-ranging experience adds additional leadership and project development expertise to an already strong in-country exploration team, led by Alvaro Fernández-Baca, VP Exploration.

Dr. Graham Carman, President and Chief Executive Officer of Tinka Resources, stated: "It is with great enthusiasm that we welcome Ken Engquist as Tinka's manager of our Ayawilca Project PEA. Ken brings a broad background of knowledge to Tinka, with his experience in both major and junior company development projects.  His experience is very relevant for Tinka given his intimate involvement with Arizona Mining's Hermosa project in the USA and, before that Nevsun Resources' Timok project in Serbia…”

Tinka Resources Limited (TKRFF), closed Wednesday's trading session at $0.24, up 2.13%, on 48,000 volume with 10 trades. The average volume for the last 3 months is 46,448 and the stock's 52-week low/high is $0.207/$0.625.

chart

Arch Biopartners, Inc. (ACHFF)

Stockwolf, Marketwired, TradingView, InvestorPoint, Infront Analytics, 4-Traders, Business Insider, Investors Hangout, OTC Markets, Barchart, Wallet Investor, Wall Street Alerts, Stockwatch, Stockhouse, and MarketWatch reported earlier on Arch Biopartners, Inc. (ACHFF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Arch Biopartners, Inc. is a portfolio-based biotechnology company listed on the OTC Markets Group’s OTCQB. It focuses on the development of unique technologies that have the potential to make a major medical or commercial impact. Arch Biopartners has its corporate headquarters in Toronto, Ontario.

Arch has established a varied portfolio that includes Metablok (LSALT peptide). This is a potential treatment for inflammation, sepsis and cancer metastasis. The Company’s portfolio also includes AB569. This is a potential new treatment for antibiotic resistant bacterial infections in the lung, urinary tract or wounds.

In addition, Arch Biopartners’ portfolio includes ‘Borg’ peptide coatings. These coatings increase corrosion resistance and lessen bacterial biofilm on different medical grade metals and plastics. The Company’s two lead commercial technologies are MetaMx and ABP569.

Metablok (renamed “LSALT peptide” in Arch Biopartners communications with the Food and Drug Administration [FDA]) is a novel peptide drug candidate in the Company development pipeline. It is a potential treatment for inflammation, sepsis and cancer metastasis.

MetaMx™ consists of novel, synthetic peptides that target and attach to BTICs and invasive glioma cells. This is for the purpose of imaging, diagnosis, and developing targeted therapies to improve patient outcomes and survival rates among glioblastoma patients.

In December, Arch Biopartners announced it created a 100 percent owned subsidiary in Australia, named Arch Clinical Pty Ltd. It created this subsidiary to pursue an application to perform a Phase I safety trial in Australia for Metablok, Arch’s lead drug candidate for treating acute kidney injury.

The Phase I study will be a double-blind, placebo-controlled, randomized, single and multiple ascending dose study. It will evaluate the safety and pharmacokinetic profile of Metablok (LSALT Peptide) in healthy participants. A successful Phase I trial will be followed by a Phase II trial to investigate Metablok’s effectiveness in the prevention of acute kidney injury in cardiac surgery patients.

Arch Biopartners, Inc. (ACHFF), closed Wednesday's trading session at $0.948, up 5.45%, on 5,900 volume with 1 trade. The average volume for the last 3 months is 974 and the stock's 52-week low/high is $0.355/$1.37.

chart

Integrated Cannabis Company, Inc. (ICNAF)

Awesome Penny Stocks, Wallstreet Online, Investors Hangout, MarketWatch, InvestorsHub, Stockwatch, Market News Updates, Wallet Investor, TradingView, The Venture Report, Market Chameleon, BioSpace, Stockhouse, OTC Markets, CannaBizNetwork, and Barchart reported earlier on Integrated Cannabis Company, Inc. (ICNAF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Integrated Cannabis Company, Inc.’s emphasis is health and creating health and lifestyle products using advanced delivery systems and formulations. The Company consists of dedicated scientists and product engineers. The Company was formerly known as CNRP Mining, Inc. It changed its corporate name to Integrated Cannabis Company, Inc. in June 2018. Integrated Cannabis Company is headquartered in Vancouver, British Columbia.

The Company’s X-SPRAYS™ product line consists of eight market ready orally ingested spray products. Four products available are infused with hemp-based cannabidiol (CBD). Four products are formulated without a cannabidiol (CBD) infusion. These products are highly bioavailable; the active ingredients in the sprays are already fully dissolved. Consequently, the vitamins and minerals do not need to be further broken down once swallowed. They are immediately available for use by the body.

The X-SPRAYS™ product line is packaged in precise, metered dose and convenient spray tubes. This includes a child-resistant version. Integrated Cannabis Company’s CBD is hemp derived from Colorado. Its products are made in Arizona.

Integrated Cannabis Company announced in September 2018 the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in Colorado. The THC product uses the same nanotechnology used to enhance the CBD-infused X-SPRAYS™. This results in higher bioavailability and speedier uptake versus capsules or powder. Integrated Cannabis continues to enhance the flavor profiles so as to find an ideal formula.

Earlier in November, Integrated Cannabis Company announced the completion of a Definitive Agreement to distribute X-SPRAYS™ products throughout the clinics and doctors' offices of Empower Clinics, Inc.  Empower is a leading owner and operator of medical cannabis and wellness clinics in the United States. Moreover, Integrated Cannabis has received its initial purchase order from Empower for a selection of X-SPRAYS™ products.

Today, New Age Brands announced that New Age Brands’ fully-owned subsidiaries, We Are Kured, LLC and Drink Fresh Water LLC, have teamed up with Integrated Cannabis and their X-SPRAYS™ product line, to bring a unique CBD concept to the Colorado X Games on January 25 – 27, 2019. As of last week, the City of Aspen approved the first ever CBD pop-up retail store in their city limits. Kured, Fresh Water and X-SPRAYS™ have approval to sell their products to consumers over the age of 18+ out of the Bootsy Bellows event center in the heart of Aspen, Colorado.

Integrated Cannabis Company, Inc. (ICNAF), closed Wednesday's trading session at $0.28, up 9.12%, on 96,515 volume with 67 trades. The average volume for the last 3 months is 540,932 and the stock's 52-week low/high is $0.209/$1.58.

chart

Elev8 Brands, Inc. (VATE)

Dividend Investor, Penny Stock Hub, Penny Stock Tweets, Investor Place, Otc.Watch, Market Screener, YCharts, Barchart, Stockwatch, Investors Hangout, The Street, Insider Financial, InvestorsHub, MarketWatch, GuruFocus, Stockhouse, and Wallet Investor reported on Elev8 Brands, Inc. (VATE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Elev8 Brands, Inc. is a holding company centered on the commercial development of hemp and CBD-based products. The Company specializes in the development and marketing of products for the fitness and wellness markets. Elev8 Brands is founded based on creating high-quality, sustainable, products for health-conscious consumers. Zoe CBD is a wholly-owned subsidiary of the Company.

Elev8 Brands has its corporate headquarters in the State of Florida. The Company previously went by the name PLAD, Inc. It changed its name to Elev8 Brands, Inc. in December of 2016. The Company announced on October 15, 2018 that it was approved for trading on the OTCQB Venture Market.

The Company’s Zoe CBD subsidiary concentrates on the development and marketing of CBD-based products. These include CBD Tinctures, CBD E-Juice, CBD Lotion, as well as CBD Salve.

In October, Canbiola, Inc. (OTC: CANB) announce it signed a manufacturing and supply agreement with Elev8 Brands for the manufacturing of its new Zoe CBD CryoGel. Canbiola is a manufacturer of proprietary CBD non-psychoactive cannabinoid products extracted from the hemp plant. The all-new CryoGel is an all-natural gel. It helps to relieve pain. In addition, it is Vegan, Non-GMO, Non-GE, and made with all-natural and organic components. CryoGel is a quick-acting all-natural infused product that is 99.9 percent pure CBD.

Last Friday, Elev8 Brands announced that the first flavor of Elev8 Hemp’s New CBD Iced Tea will be Lemon. Its research concluded one of the most common and popular flavors of iced tea is Lemon. The Company’s mission is to introduce CBD to consumers via premium everyday consumable products. Elev8 Hemp chose to begin with an already familiar flavor. Last week, it concluded the formulation process of its CBD Lemon Iced Tea.

Mr. Ryan Medico, Elev8 Brands’ Chief Executive Officer, stated, “We are very pleased to be bringing both a CBD Coffee and CBD Tea to market in the RTD category. Lemon flavored CBD Iced Tea will be our first flavor to market as we believe it will appeal more to the masses.”

Elev8 Brands, Inc. (VATE), closed Wednesday's trading session at $0.0385, up 1.85%, on 2,793,285 volume with 95 trades. The average volume for the last 3 months is 4,017,168 and the stock's 52-week low/high is $0.019/$0.167.

chart

Vilacto Bio, Inc. (VIBI)

OTC Markets and The Street reported on Vilacto Bio, Inc. (VIBI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vilacto Bio, Inc. is a biotechnology company listed on the OTCQB. It has developed the now fully patented Lactoactive® (Lactoactive molecule). In manifold studies, Lactoactive® has demonstrated above average effect treating conditions such as inflammatory diseases, diabetes, psoriasis, skin aging, and skin issues in different levels. At present, the Company’s products are available on the market as Vilact®. Vilacto Bio has its corporate headquarters in New York, New York.

The Company’s goal is to be the foremost biotechnology company centered on commercializing unique pharmaceutical cosmeceutical products formulated or reformulated with Lactoactive® as nanoparticle according to its patented properties. Vilacto Bio’s aim is to further develop its Lactoactive® molecule for increasing the quality of its retail and medical skin cream products, and also licensing out its Lactoactive® molecule for the pharmaceutical industry.

Lactoactive® is highly refined colostrum, developed to provide first-rate results for people requiring healing or relief from a range of skin issues. Lactoactive® is a refined processing of colostrum combined with hyaluronic acid. During this process, the ingredients attain a much better effect than previously seen. The yield of protein content is as high as 82 percent, versus the normal 50-60 percent. Proteins in Vilact® survive longer without being degraded by enzymes. This enables them to work longer in the skin.

In July, Vilacto Bio announced that it launched its U.S. eCommerce portal. At this site, U.S. consumers can obtain the trademarked skin care line Vilact®, which contains Lactoactive®. Vilacto Bio recently presented its latest product, Vilact Cuticle cream, developed in cooperation with Danish podiatrists. Lactoactive, the ingredient molecule in Vilact Cuticle cream, works to help with skin challenges. Danish podiatrists have demonstrated its use with speedier patient recovery.

Vilacto Bio announced in July that the upgrade of its production facility was completed. The upgrade included an additional storage container, improved mixing machines, as well as an upscale filtration unit. The upgrade allows the Company to boost its production of its Lactoactive® molecule and output.

Vilacto Bio will present at the China (Wuxi) International Industrial Design Expo 2017, which will take place September 21-24, 2017 at the Wuxi region, one of mainland China’s most innovative cities, organized by the Department of Science & Technology. Vilacto Bio will be at this Expo to expand its exposure in Asia, meeting with partners, distributors and investors.

Vilacto Bio, Inc. (VIBI), closed Wednesday's trading session at $0.021, up 7.20%, on 497,450 volume with 21 trades. The average volume for the last 3 months is 277,213 and the stock's 52-week low/high is $0.015/$0.80.

chart

EPHS Holdings, Inc. (STNN)

MarketWatch, YCharts, Dividend Investor, last10k, Simply Wall St, Stockopedia, The Stock Market Watch, The Street, Street Insider, Market Chameleon, Stockwatch, InvestorsHub, GuruFocus, Wallet Investor, Morningstar, and Marketbeat reported earlier on EPHS Holdings, Inc. (STNN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

EPHS Holdings, Inc., via its subsidiary, Emerald Plants Health Source, Inc., intends to cultivate and distribute cannabis in Canada. The Company’s aim is to secure a commercial cultivation license identified as a license for access to cannabis for medical purposes regulation (ACMPR). OTCQB-listed, EPHS Holdings is headquartered in Boynton Beach, Florida.

Only upon receipt of the ACMPR may the Company commence its commercial operations. After Health Canada grants EPHS its ACMPR license, the Company will begin cultivation of its first cannabis crops.

The initial crops will be submitted to Health Canada as part of the Company’s application for a sales license. EPHS plans to begin commercial sales within four months of receiving the ACMPR license.

Emerald Plants Health Source is EPHS Holdings’ sole operating subsidiary. Emerald is based in the Province of Quebec. It conducts its operations entirely within Canada. Upon Emerald obtaining its ACMPR, it will be required to apply for an additional sales license.

This past October, EPHS Holdings, together with its joint venture (JV) partner, Merritt Valley Cannabis, announced it received approval for their pending commercial cultivation license, (ACMPR), from Health Canada. The license was received on Friday, October 12, 2018. EPHS may now produce cannabis for medicinal and recreational purposes. This includes licensed products such as dried or fresh cannabis flower, cannabis oil, starting materials and plants at EPHS’s state-of-the art facility in Quebec.

Also in October, EPHS Holdings, together with its JV partner, Merritt Valley Cannabis, announced its Montreal cultivation plans started, as per Health Canada sales license regulations and inspections. The EPHS state-of-the-art facility in Montreal is ready for immediate production and scale. EPHS is starting with the Health Canada sales license process.

EPHS will continue to scale cannabis production at its Merritt site with the granting of additional Health Canada licenses. Ground breaking is scheduled for early this year for Phase one of the 30,000 square foot Cannabis Campus. The expectation is that the campus will produce a supply of 5,500 plus kilograms of cannabis per year by early 2020.

EPHS Holdings, Inc. (STNN), closed Wednesday's trading session at $1.60, up 52.38%, on 2,020 volume with 3 trades. The average volume for the last 3 months is 6,506 and the stock's 52-week low/high is $0.15/$4.40.

chart

BioElectronics Corporation (BIEL)

StreetInsider, Barchart, and InvestorsHub reported on BioElectronics Corporation (BIEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioElectronics Corporation is a leader in non-invasive electroceuticals. The Company is the maker of an industry leading family of disposable, drug-free, pain therapy devices. BioElectronics’ unique medical devices safely and effectively treat chronic and acute pain through an innovative mechanism of non-invasive sub-sensory neuromodulation. BioElectronics is based in Frederick, Maryland and the Company lists on the OTC Markets.

BioElectronics’ products include RecoveryRx® and ActiPatch. RecoveryRx® uses pulsed electromagnetic therapy to lessen pain and inflammation resulting in accelerated patient recovery and improved comfort. For medical professionals, the RecoveryRx® medical device provides a safe and cost-effective pain management therapy.

ActiPatch® provides advanced long-lasting chronic pain relief using Electromagnetic Pulse Therapy. It is a new and clinically proven drug free technology in the battle against chronic pain.

Bioelectronics’ products also include Smart Insole™, Allay® Menstrual Pain Relief, and HealFast® Veterinary Pain Relief. The Smart Insole™ consists of Electro-Pulse micro medical devices. These are embedded in comfortable heel gel inserts. HealFast® Therapy is a drug-free therapy for horses, cats and dogs. It reduces swelling and pain while it speeds up healing of muscle and tendon injuries, sores, and incisions. Allay® is an award-winning drug-free micro medical device. It utilizes Electromagnetic Pulse Therapy to lessen menstrual pain and discomfort.

BioElectronics announced in May 2018 that B. Braun Ltd, of Sheffield, United Kingdom (UK) completed development of its same day surgical TOTAL Pathway program for joint replacements, which includes BioElectronics’ medical devices. The program is being launched by B. Braun’s UK Group to improve care and reduce the UK healthcare cost of its 160,000 yearly hip and knee replacement procedures.

This month, BioElectronics announced the publication of an article in the October 2018 edition of the European Biopharmaceutical Review. Titled “Effective Electroceuticals,” this article provides insights into how electroceuticals (devices that provide electrical therapy) are set to transform chronic pain management in the 21st century. The article was authored by Dr. Kenneth McLeod, Ph.D., Director of the Clinical Science and Engineering Research Laboratory at the State University of New York, Binghamton and Dr. Sree Koneru, Ph.D., VP of Product Development at BioElectronics.

BioElectronics Corporation (BIEL), closed Wednesday's trading session at $0.0006, even for the day, on 21,085,615 volume with 31 trades. The average volume for the last 3 months is 60,251,896 and the stock's 52-week low/high is $0.0005/$0.005.

chart

Prophecy Development Corp. (PRPCF)

InvestorIntel, Marketwired, Wallmine, GuruFocus, Wallet Investor, Junior Mining Network, OTC Markets, Stockhouse, The StreetWise Reports, Barchart, 4-Traders, InvestorsHub, Business Wire, Uptick Newswire, and TradingView reported earlier on Prophecy Development Corp. (PRPCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Prophecy Development Corp. engages in the acquisition, exploration, and development of mineral and energy projects. Its main goal is to develop the Gibellini primary vanadium mining project in the Battle Mountain area in northeastern Nevada to production. The design of the Gibellini vanadium project is to be an open pit, heap leach operation. OTCQX-listed, Prophecy Development is headquartered in Vancouver, British Columbia.

In June of 2018, Prophecy Development announced the filing of a technical report prepared in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects (NI 43-101) regarding a Preliminary Economic Assessment (PEA) for the Company’s Gibellini vanadium project in Eureka, Nevada. The project is roughly 25 miles south of the town of Eureka.

The PEA reported an after-tax cumulative cash flow of $601.5 million, an Internal Rate of Return (IRR) of 50.8 percent, a Net Present Value (NPV) of $338.3 million at a 7 percent discount rate and a 1.72 years payback on investment from start-up assuming an average vanadium pentoxide price (V2O5) of $12.73 per pound.

Prophecy Development also has its Pulacayo (Silver-Zinc-Lead) project. This Project is in Bolivia, 107 km northeast of Sumitomo Corporation’s San Cristobal silver mine; 185 km southwest of Coeur Mining, Inc.’s San Bartolome silver mine; and 139 km north of Pan American Silver Corp.’s San Vicente silver mine.

In addition, the Company has its Titan (Titanium Vanadium) Project. This Project is at Flett and Angus Townships, 120 kilometers northeast of Sudbury, Ontario. The Property consists of 262 contiguous hectares consisting of 17 patented claims.

Prophecy Development announced in October 2018 that it executed a lease agreement with an arms-length private Mongolian company. The Lessee plans to perform mining operations at Prophecy's Ulaan Ovoo coal mine. It will pay Prophecy US$2 (Production Royalty) for every tonne of coal shipped from the Ulaan Ovoo site premises. Ulaan Ovoo has nameplate production capacity of 2 million tonnes annually.

Last month, Prophecy Development announced that it selected M3 Engineering & Technology Corporation (M3) of Tucson, Arizona to provide engineering, procurement, construction and management services (EPCM) for its Gibellini Vanadium Project in response to its Request for Proposal. M3 was chosen for its particular experience in heap leach engineering, and construction expertise in arid environments such as Nevada and Arizona.

Prophecy Development Corp. (PRPCF), closed Wednesday's trading session at $0.2006, up 0.30%, on 205,876 volume with 40 trades. The average volume for the last 3 months is 416,803 and the stock's 52-week low/high is $0.086/$3.65.

chart

BTCS, Inc. (BTCS)

RedChip, PennyPro, Stock Commander, HotStockProfits, Value Penny Stocks, Money Morning, 1-2-3 Stock Alerts, Fortune Stock Alerts, Penny Stock Circle, StockMarketQuote.us, StockMister, SmallCapVoice, AddictivePennyStocks, Bullseyestox.com, PennyStockRumors.net, PennyStocks Forever, PricelessPenny, and TheMicrocapNews reported on BTCS, Inc. (BTCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BTCS, Inc. is a blockchain technology focused company headquartered in Silver Spring, Maryland. The Company is an early entrant in the Digital Asset market. In addition, it is one of the first U.S. publicly traded companies engaged with Digital Assets and blockchain technologies. Blockchains are distributed public ledgers, which can fundamentally influence all industries around the world that require trust and rely on or use record keeping. The Company has a record of accomplishment of accurate digital asset trend prediction. BTCS’ shares trade on the OTC Markets Group’s OTCQB.

BTCS’ plan (subject to additional financing) is to create a portfolio of digital assets, such as bitcoin and other "protocol tokens", to provide investors a diversified pure-play exposure to the bitcoin and blockchain industries. The Company’s intention is to acquire digital assets by way of open market purchases; and participating in initial digital asset offerings (or initial coin offerings).

Furthermore, BTCS may acquire digital assets through resuming its transaction verification services business (or mining) via outsourced data centers and earning rewards in digital assets by securing their respective blockchains. Moreover, the Company is concentrating on growth via acquisition.

A blockchain is secured and maintained by a network of specialized servers (nodes) globally. All transactions are publicly available on a blockchain. Transactions undergo verification and confirmation through nodes worldwide before being added to a blockchain.

Last month, BTCS announced the appointment of Mr. Jonathon R. Read to its Board of Directors. Mr. Read has held many executive positions with domestic and global companies over a career, which spans more than 35 years. Most recently, from 2013 to the present, he has served as Managing Partner of Quadratam1 LLC (Scottsdale, Arizona) a firm specializing in providing financial and organizational consulting services for growth-stage companies in the United States and China.

Before that, Mr. Read served as Chief Executive Officer (CEO) or President of Timefire VR, Inc., previously known as EnergyTek Corp. During his tenure, he repositioned, re-financed, and merged the company into an entity centered on the virtual reality sector.

Mr. Charles Allen, BTCS CEO, said, "Jonathon brings a wealth of public company expertise to our board. As we move forward on our plans to build a vertically-integrated operation in the burgeoning blockchain space, Jonathon's experience should add tremendous value."

BTCS, Inc. (BTCS), closed Wednesday's trading session at $0.0158, up 1.94%, on 1,007,766 volume with 74 trades. The average volume for the last 3 months is 1,795,304 and the stock's 52-week low/high is $0.015/$0.235.

chart

AIT Therapeutics, Inc. (AITB)

NetworkNewsWire, Zacks, TradingView, Barchart, Insider Financial, Street Insider, last10k, Wallet Investor, GuruFocus, Wolfstreet, MarketWatch, Emerging Growth, Morningstar, Stockhouse, Stockopedia, Real Investment Advice, 4-Traders, Tip Ranks, and Investor Place reported earlier on AIT Therapeutics, Inc. (AITB), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

AIT Therapeutics, Inc. is a clinical-stage medical device and biopharmaceutical company listed on the OTCQB. It concentrates on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions. These include serious lung infections and pulmonary hypertension. AIT Therapeutics is headquartered in Garden City, New York. The Company also has an office in Ness Ziona, Israel.

Currently, AIT Therapeutics is applying its therapeutic expertise to treat lower respiratory tract infections not effectively addressed with present standards of care, and also pulmonary hypertension, in different settings. AIT is now advancing its ground-breaking NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections. This includes nontuberculous mycobacteria (NTM).

The Company’s propriety generator and delivery system generates NO from room air. This eliminates the need for expensive and cumbersome cylinders. AIT’s system allows for many significant advantages over approved NO cylinder based systems currently used in hospitals around the world and may allow for use in the home setting.

NO is recognized as a vital molecule involved in numerous physiological and pathological processes. NO is naturally produced by the body’s immune system to provide a first line of defense against invading pathogens. NO is a powerful molecule and has a short half-life of a few seconds in the blood. This enables it to be cleared quickly from the body.

Last week, AIT Therapeutics announced that, having earlier signed a Letter of Intent (LOI), a definitive agreement to license the commercial rights for its novel cylinder free ventilator compatible nitric oxide (NO) generator and phasic-flow delivery system for use in the hospital setting at NO concentrations < 80 ppm to a commercial partner is close to being finalized. The partner will be named upon the signing of a definitive agreement and Board approvals from both companies.

Today, AIT Therapeutics announced the appointment of Mr. Duncan Fatkin to the newly created position of Chief Commercial Officer. Mr. Fatkin will be responsible for leading AIT's commercial activities. He has a successful track record in the international medical device and biopharmaceutical industries, building out commercial capabilities, leading marketing and sales teams, and cultivating strong thought leader relationships across numerous specialties.

AIT Therapeutics, Inc. (AITB), closed Wednesday's trading session at $4.40, down 5.38%, on 17,050 volume with 36 trades. The average volume for the last 3 months is 10,185 and the stock's 52-week low/high is $2.05/$5.49.

chart

Citius Pharmaceuticals, Inc. (CTXR)

MicroCapDaily, Stock Commander, Penny Stock Prodigy, DSR News, PHUB News, Damn Good Penny Picks, Penny Picks, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, OTCMagic, Penny Stock Newsletter, and PREPUMP STOCKS reported previously on Citius Pharmaceuticals, Inc. (CTXR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products. The Company’s concentration is on anti-infectives, cancer care, and innovative prescription products utilizing unique, patented, or proprietary formulations of earlier approved active pharmaceutical ingredients. Citius Pharmaceuticals is headquartered in Cranford, New Jersey.

The Company is now advancing two proprietary product candidates: the Mino-Lok™ product and a hydrocortisone-lidocaine formulation. The Mino-Lok™ product is advancing to Phase 3 clinical studies. The Mino-Lok™ product is an antibiotic lock solution. It is used to treat patients with catheter-related bloodstream infections (CRBSIs). Mino-Lok™ is under investigation and not approved for commercial use.

Citius Pharmaceuticals is developing a proprietary topical formulation of hydrocortisone (3%) and lidocaine (5%) to provide anti-inflammatory and anesthetic relief to persons suffering from Grade I and II hemorrhoids. The Company has achieved positive results from a Phase 2a study for hydrocortisone-lidocaine formulation for Grade I and II hemorrhoids.

Citius Pharmaceuticals has commenced the pivotal Phase 3 clinical trial Mino-Lok™. This is the above-mentioned antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs). Mino-Lok™ is undergoing development as an adjunctive therapy for the treatment of catheter-related or central line associated bloodstream infection (CRBSI/CLABSI). Mino-Lok™ together with suitable systemic antibiotic(s), is used to preserve central venous access and to avoid the complications and morbidities associated with catheter removal and reinsertion.

The Company has obtained top line data from a survey of 31 physicians clearly showing a need for catheter salvage in patients with indwelling central venous lines, especially when the catheter is a tunneled or an implanted port. Nineteen Infectious Disease experts and 12 Intensivists surveyed all agreed that salvage would be preferable to catheter exchange, fearing that catheter misplacements, blood clots, or vessel punctures can potentially occur during reinsertion. Most were also concerned that viable venous access may not be available. The survey was conducted by a third party in January of this year.

In March 2017, Citius Pharmaceuticals announced that it concluded negotiations to add South America to its global license for Mino-Lok™. South America was the only territory that was not included in the original sub-license between Novel Anti-Infective Technologies, LLC, an affiliate of MD Anderson Cancer Center (MDACC), and Leonard-Meron Biosciences, Inc. (LMB), a wholly-owned subsidiary of Citius Pharmaceuticals.

Citius Pharmaceuticals, Inc. (CTXR), closed Wednesday's trading session at $1.08, up 3.85%, on 21,152 volume with 109 trades. The average volume for the last 3 months is 87,970 and the stock's 52-week low/high is $0.936/$4.59.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, Tip Ranks, Barchart, Stock Digest, Amigo Bulls, Dividend Investor, Stockhouse, Private Capital News Wire, Stockwatch, Equity Clock, The Street, Marketwired, YCharts, Capital Cube, and Street Insider reported on DXI Energy, Inc. (DXIEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. It is an upstream oil and gas exploration and production company. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch region in British Columbia (B.C.). OTCQB-listed, DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia.

In Colorado’s Piceance Basin, DXI Energy has 24,407 net acres. In the Peace River Arch area in B.C. it has 13,093 net acres. Regarding the Company’s project areas, in the Piceance Basin in northwest Colorado, it has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate.

DXI Energy’s land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases).

The Woodrush Project in northeastern B.C. covers 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI Energy is the operator. The Company owns 99 percent of this Project. The Company has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

DXI also has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells.

On December 12, 2018, DXI Energy announced that it formally activated its application to the Province of British Columbia Oil & Gas Commission (BCOGC) to drill an oil and gas exploration well at c-089-E/94-1-H roughly one km southeast of the main production facilities at Woodrush. The goal is a significant 3D-seismic defined Halfway anomaly resulting from an advanced Israeli-developed (Paradigm) seismic reprocessing program undertaken by DXI over the past two years - never used in North America.

The expectation is that the well will be spudded before March 15, 2019, subject to completion of financing activities now in progress. Success of the well will lead to the future drilling of more large anomalies also imaged using this technique on DXI Energy lands.

DXI Energy, Inc. (DXIEF), closed Wednesday's trading session at $0.0309, up 5.46%, on 32,542 volume with 7 trades. The average volume for the last 3 months is 97,811 and the stock's 52-week low/high is $0.0104/$0.1002.

chart

Q BioMed, Inc. (QBIO)

Penny Stock Tweets, Super Stock Screener, Insider Financial, Proactive Investors, SeeThruEquityResearch, Market Screener, Business Insider, Tip Ranks, Stock News Now, Investing News, Simply Wall St, StockPicksNYC, and Barchart reported previously on Q BioMed, Inc. (QBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a commercial stage biomedical acceleration and development company. Its commitment is to licensing and acquiring biomedical assets across the healthcare spectrum. The Company previously went by the name ISMO Tech Solutions, Inc. It changed its name to Q BioMed, Inc. in July 2015.Q BioMed has its corporate headquarters in New York, New York.

The Company’s dedication is to provide these target assets the strategic resources, developmental support, and expansion capital they need to ensure they meet their developmental potential, enabling them to provide products to patients in need. Q BioMed’s mission is to license and acquire innovative life sciences assets from academia or small private companies.

Q BioMed has manifold assets across a wide variety of healthcare related products, companies, and sectors. These assets will undergo development to provide returns through organic growth or out-licensing, sale, or be spun out into new public companies. The Company is focusing on clinical stage and unique products where the technical, regulatory, and commercial risks have been reduced or significant valuation modulations are pending.

Q BioMed has started production of Strontium-89 Chloride - a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain. AB-Rated Strontium Chloride Sr89 Injection USP (Sr89) can be used in combination with, or to lessen the requirement for opiate based drugs, as well as in combination with cancer therapeutic drugs.

Additionally, Q BioMed is developing an innovative molecule delivered in an easy-to-administer eye drop designed to repair the normal flow of fluid in the eye resulting in the lessening of IOP (Intraocular Pressure) . The Company, together with its partner, Mannin Research, Inc, is the only company targeting this mechanism of action.

This past November, Q BioMed announced that it entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™, from GE Healthcare. This agreement gives Q BioMed ownership of the brand, trademarks and market authorizations in 22 countries. Moreover, all historical and current sales and distribution data related to those market authorizations will be assigned or transferred to Q BioMed to allow for as seamless a transition as possible in all markets.

Denis Corin, Q BioMed Chief Executive Officer, said, "This is a major deal for Q BioMed. Strategically, it affirms our belief in this drug as an effective and underutilized non-opioid therapy for the treatment of debilitating pain associated with skeletal cancer metastases…”

Q BioMed, Inc. (QBIO), closed Wednesday's trading session at $1.29, up 35.79%, on 90,212 volume with 125 trades. The average volume for the last 3 months is 54,982 and the stock's 52-week low/high is $0.89/$4.59.

chart

Agritek Holdings, Inc. (AGTK)

CFN Media Group, Promotion Stock Secrets, PennyPro, SmallCapVoice, and Cannabis Financial Network News reported on Agritek Holdings, Inc. (AGTK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Formed in 2010, Agritek Holdings, Inc. is a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector. The Company provides innovative technology and agricultural solutions for the medicinal and recreational cannabis industry. Currently, Agritek owns property in Colorado approved for cultivation, and manufacturing capabilities through California partnerships. It also owns a number of Hemp and cannabis brands for distribution including "Hemp Pops" and "California Premiums". Agritek Holdings is headquartered in Miami, Florida. The Company has a satellite office in San Juan, Puerto Rico

Agritek does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene United States law or the Controlled Substances Act. It does not intend to do so in the future. The Company’s solution is an integrated platform designed for commercialization in three high-value segments of the global cannabis market – Real Estate, AGTK Brands/IP, and Infrastructure.

Agritek’s Colorado property is 80-Acres approved for cannabis cultivation or manufacturing facility in Pueblo, Colorado. Its Puerto Rico property is a 25,000-sq. ft. licensed cannabis cultivation and manufacturing facility. Agritek’s Canada property is a cannabis friendly "Bud & Breakfast" concept. It is one 1-hour from Quebec City. It is on 15-acres that includes nine guest rooms plus a separate detached grow facility.

Agritek’s brands are a premium positioned set of consumer brands for medical wellness and recreational use. Agritek owns a number of hemp and cannabis brands for distribution. These include MD Vapes, MicroDose Strips, and the above-mentioned "Hemp Pops" and "California Premiums."

Agritek Holdings announced this past April that it completed, and fully executed, a five-year operational and exclusive licensing agreement with a 25,000-sq. ft. and one of the largest approved cultivation facilities in San Juan, Puerto Rico. The Company will be the exclusive funding source, and supervise all infrastructure buildout, equipment lease/finance, security systems and personnel and provide access of experienced Colorado and California cultivation crews to ensure the facility meets all standard operating procedures as set forth by the Department of Health of Puerto Rico.

With the five-year operational contract and licensing agreement, Agritek will receive revenue in the form of property rent, licensing fees on all vaporizer and edible brands, equipment and lighting rental and financing fees along with equity interest in the property.

Also, in May, Agritek Holdings announced that it executed a land purchase agreement to purchase a "420 Style" resort and estate property about one hour outside of Quebec City, Quebec. This 15-acre estate comprises nine innovative guest suites and horse stables. It is within walking distance to a public golf course that the Company will have ownership in for guests staying at the resort. A separate structure will serve as a small grow facility run by patient employees and caretakers on the property that may be toured by guests of the facility.

This month, Agritek Holdings announced that Phase One of construction is commencing this month at the 1919 Clinic's 25,000 square foot cultivation and manufacturing facility located in San Juan, Puerto Rico. Agritek will provide funding for the build out of the operation, extraction and all equipment, and cultivation experts under the Agritek team via its executed five-year Operations and Licensing Agreement with 1919 Clinic.

Last week, Agritek Holdings announced its initial orders from its' state licensed manufacturer for its brand "MicroDose" Oral Strips or "MD Strips" for the medicinal market of California. First orders and samples are being sent to dispensaries and local delivery services in San Diego and Orange County this month. Agritek will provide the licensing and packaging to produce the exclusive line of 10 mg and 50 mg oral strips as a medicinal alternative for patients.

Agritek Holdings, Inc. (AGTK), closed Wednesday's trading session at $0.0038, up 5.56%, on 9,508,513 volume with 125 trades. The average volume for the last 3 months is 14,259,534 and the stock's 52-week low/high is $0.0017/$0.0545.

chart

The QualityStocks Company Corner

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, announced today the launch of its multi-channel blockchain-powered payments application across multiple touch points including face-to-face via smart payment terminals and electronic commerce as well as via API.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.13, up 7.17%, on 66,115 volume with 365 trades. The average volume for the last 3 months is 319,227 and the stock's 52-week low/high is $3.75/$15.50.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) on Monday announced the closing of its 100% acquisition of LTYR Logistics, LLC (“LTYR”), a California-based cannabis distribution company. To view the full press release, visit: http://nnw.fm/C1M3m. Also today, the company was featured in a report by CannabisNewsWire examining how a recent survey has discovered that the majority of veterinarians want the laws on marijuana relaxed for both pets and humans.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $2.919, up 19.63%, on 70,439 volume with 108 trades. The average volume for the last 3 months is 96,830 and the stock's 52-week low/high is $2.035/$16.00.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1), announces that as of calendar year-end, 7ACRES has 19 completed flowering rooms and is on track for all 25 flowering rooms to be completed in March 2019. Once completed, 7ACRES will have a greenhouse footprint of approximately 300,000 square feet, with the total facility reaching over 440,000 square feet.  Supreme Cannabis expects 7ACRES to reach its estimated annual output of 50,000 kg by the middle of calendar 2019.  Also today, the company was featured in a report by CannabisNewsWire examining how a recent survey has discovered that the majority of veterinarians want the laws on marijuana relaxed for both pets and humans.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.09, up 14.26%, on 371,119 volume with 392 trades. The average volume for the last 3 months is 556,377 and the stock's 52-week low/high is $0.85/$2.79.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp.’s (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Irgon Lithium Mine project in southern Manitoba has the potential to spur market prospects to new heights. Coined the “white petroleum,” lithium continues to be sought for its critical importance in the manufacturing of lithium batteries that power most of today’s electronics.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1484, up 18.72%, on 61,858 volume with 16 trades. The average volume for the last 3 months is 74,687 and the stock's 52-week low/high is $0.1155/$0.92.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

Diversified holding company DPW Holdings (NYSE American: DPW) recently announced that two of the company’s subsidiaries secured $700,000 in debt financing, driving its effort to cut the order backlog for the defense sector businesses of Coolisys Technologies, Inc. including its subsidiary, Enertec Systems 2001, Ltd. and Microphase Corporation Inc. To view the full press release, visit: http://nnw.fm/7Oj5W.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.1178, up 14.93%, on 1,968,488 volume with 3,433 trades. The average volume for the last 3 months is 1,529,411 and the stock's 52-week low/high is $0.09/$3.59.

Recent News

chart

Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTCQB: SHRV) is a diversified holding company located in Plano, Texas, that owns, operates or controls a variety of companies in the direct selling industry. The company works to equip and promote the success of home-based entrepreneurs, which it has dubbed ‘Elepreneurs’. SHRV has seen significant growth in 2018 and looks forward to further expansion in 2019.

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.265, up 6.00%, on 800 volume with 2 trades. The average volume for the last 3 months is 10,833 and the stock's 52-week low/high is $0.125/$0.589.

Recent News

chart

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

The forecast for cobalt in the coming few years is a positive one, with demand set to grow and prices expected to increase 30 percent by mid-2019, according to analysts. The cobalt price reached near decades high in March 2018, but then dropped for a few months and is now expected to reach $70,000 per tonne by the middle of 2019 and $80,000 per tonne by 2020, as noted by a Capital Economics report (http://nnw.fm/i8hNN). The increase in both demand and pricing will most likely benefit alternative cobalt producers such as North American pure-play cobalt company First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC).

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.13, up 8.33%, on 60,102 volume with 23 trades. The average volume for the last 3 months is 197,858 and the stock's 52-week low/high is $0.1143/$1.289.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

With California’s legal cannabis market expected to grow “more than 18 percent annually to hit $5.6 billion by 2020” (http://nnw.fm/wMBb4) and the hydroponics market on “a CAGR of 6.5%” (http://nnw.fm/uBW3f) from 2018 to 2023, California-based Sugarmade, Inc. (OTCQB: SGMD) has positioned itself at the confluence of two great market movements.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1014, up 6.40%, on 684,807 volume with 77 trades. The average volume for the last 3 months is 1,785,262 and the stock's 52-week low/high is $0.062/$0.43.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a 2019 outlook for the sector as the 2018 US Farm Bill law plants the seeds of a new era for the US markets. SinglePoint, Inc. (OTCQB: SING) just stated in recent news, “This is a huge win and opportunity for us. The company’s subsidiary SingleSeed.com is an ecommerce-based business that sells and supplies industrial-based hemp cannabidiol (CBD) products. As hemp has become more mainstream and now a fully federally legal commodity the company plans to add more to its offering. Ranging from Biofuel to construction materials to extracting cannabidiol used to treat various ailments and wellbeing, industrial hemp now has an opportunity to be competitive in the global marketplace.”

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0145, up 21.85%, on 10,277,367 volume with 421 trades. The average volume for the last 3 months is 4,512,718 and the stock's 52-week low/high is $0.0106/$0.1094.

Recent News

chart

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout (OTC: GOHE) together with its wholly-owned subsidiary MTrac Tech Corp. on Monday announced an update from Chief Executive Officer Vanessa Luna to provide shareholders clarity on numerous business endeavors and aspirations for the new year. To view the full press release, visit: http://nnw.fm/vgz2O.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.007, up 29.63%, on 6,774,834 volume with 110 trades. The average volume for the last 3 months is 8,642,961 and the stock's 52-week low/high is $0.0041/$0.0755.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces the imminent clinical use of a new novel, frozen formulation for its lead product candidate, Bria-IMT™, which is currently being tested in a Phase I/IIa clinical trial with pembrolizumab [KEYTRUDA®; manufactured by Merck & Co., Inc. (NYSE: MRK)], listed in ClinicalTrials.gov as NCT03328026.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0637, up 21.33%, on 2,000 volume with 2 trades. The average volume for the last 3 months is 20,641 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX: FLWR), a vertically integrated Canadian company producing premium cannabis product, is expected to weather a coming supply glut over larger companies because of its low operating costs and irradiation-free products.

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $4.32, off by 1.59%, on 33,650 volume with 71 trades. The average volume for the last 3 months is 97,872 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) on Monday reviewed the company’s achievements from 2018 as well as business plans and initiatives for 2019. To view the full press release, visit: http://nnw.fm/0plRw.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7799, off by 1.28%, on 16,335 volume with 34 trades. The average volume for the last 3 months is 88,340 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Plus Products Inc. (CSE: PLUS)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS).

Plus Products Inc. (CSE: PLUS) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLUS), closed the day's trading session at $4.60, up 2.22%, on 25,615 volume with 31 trades. The average volume for the last 3 months is 116,823 and the stock's 52-week low/high is $3.51/$7.25.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.